Published

Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment

Growing research on potential therapeutic applications of highly restricted Schedule I hallucinogens, including the ‘classic psychedelic’ psilocybin, and the entactogen 3,4-Methylenedioxymethamphet...

Open source BibTeX RIS

Bibliographic context

Journal: Drugs Education Prevention and Policy
Date: 2021-04-29
Source: OpenAlex
DOI: 10.1080/09687637.2021.1897331
PubMed: Unavailable

Authors

Johannes Thrul Albert Garcia-Romeu

Watch author

Topics and keywords

psilocybin General Other Psilocybin Hallucinogen Mental health Psychology Psychiatry Clinical psychology Psychotherapist Psychedelics and Drug Studies Chemical synthesis and alkaloids Biochemical Analysis and Sensing Techniques

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment2021-04-29

Related papers

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25 Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09 Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08 Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22 Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22